Literature DB >> 34179117

Lower Serum Irisin Levels Are Associated with Increased Abdominal Aortic Calcification in Peritoneal Dialysis Patients.

Si-Jia Zhou1, Xiao-Xiao Wang2, Wen Tang1, Qing-Feng Han1, Lian He1, Ai-Hua Zhang3.   

Abstract

INTRODUCTION: Vascular calcification (VC), with the mechanisms remaining unclear, is closely related with dialysis patients' cardiovascular mortality and all-cause mortality. Irisin is a newly identified myokine. This study aims to evaluate the serum irisin levels of peritoneal dialysis (PD) patients and their relationship with VC.
METHODS: This cross-sectional study enrolled stable PD patients in Peking University Third Hospital who were followed for >6 months. We used plain X-ray films of abdomen to quantitatively evaluate VC of abdominal aorta. VC was evaluated by abdominal aortic calcification (AAC) scores, and PD patients were divided into the high AAC score group (AAC score ≥4) and the low AAC score group (AAC score <4). Demographic data and laboratory indexes were collected. Serum irisin concentrations were measured by enzyme-linked immunosorbent assay.
RESULTS: A total of 102 PD patients were enrolled in this study, and 52 patients (51.0%) were found to have a high AAC score of ≥4. Age, diabetic mellitus proportion, pulse pressure, hypercalcemia (corrected calcium >2.54 mmol/L) rate, serum ultrasensitive C reactive protein, and AAC scores were significantly higher in the high AAC score group than those of the low AAC score group (p < 0.05). The high AAC score group had lower diastolic blood pressure, serum albumin, and serum carbon dioxide combining power compared with the low AAC score group (p < 0.05). Serum irisin levels of PD patients with a high AAC score were significantly lower than those of PD patients with a low AAC score (109.7 ± 13.1 ng/mL vs. 115.9 ± 10.1 ng/mL, p = 0.010). The multivariate logistic regression analyses showed that serum irisin, diabetic mellitus, serum ultrasensitive C reactive protein, and age were independent factors influencing the occurrence of VC in PD patients.
CONCLUSION: Our results are the first to provide a clinical evidence of the association between serum irisin and abdominal aortic calcification in PD patients. Lower irisin levels, diabetic mellitus, higher serum ultrasensitive C reactive protein, and older age could be potential predictive factors for VC in PD patients.
Copyright © 2021 by S. Karger AG, Basel.

Entities:  

Keywords:  Cardiovascular disease; Irisin; Peritoneal dialysis; Vascular calcification

Year:  2021        PMID: 34179117      PMCID: PMC8215984          DOI: 10.1159/000512514

Source DB:  PubMed          Journal:  Kidney Dis (Basel)        ISSN: 2296-9357


  25 in total

Review 1.  Crosstalk Between Muscle and Bone Via the Muscle-Myokine Irisin.

Authors:  G Colaianni; T Mongelli; S Colucci; S Cinti; Maria Grano
Journal:  Curr Osteoporos Rep       Date:  2016-08       Impact factor: 5.096

2.  Circulating irisin in relation to insulin resistance and the metabolic syndrome.

Authors:  Kyung Hee Park; Lesya Zaichenko; Mary Brinkoetter; Bindiya Thakkar; Ayse Sahin-Efe; Kyoung Eun Joung; Michael A Tsoukas; Eleni V Geladari; Joo Young Huh; Fadime Dincer; Cynthia R Davis; Judith A Crowell; Christos S Mantzoros
Journal:  J Clin Endocrinol Metab       Date:  2013-09-20       Impact factor: 5.958

3.  Presence of abdominal aortic calcification is significantly associated with all-cause and cardiovascular mortality in maintenance hemodialysis patients.

Authors:  Senji Okuno; Eiji Ishimura; Kayoko Kitatani; Yoko Fujino; Kaori Kohno; Yoshifumi Maeno; Kiyoshi Maekawa; Tomoyuki Yamakawa; Yasuo Imanishi; Masaaki Inaba; Yoshiki Nishizawa
Journal:  Am J Kidney Dis       Date:  2007-03       Impact factor: 8.860

4.  Endothelial cells exposed to phosphate and indoxyl sulphate promote vascular calcification through interleukin-8 secretion.

Authors:  Jeanne Bouabdallah; Kazem Zibara; Hawraa Issa; Gaëlle Lenglet; Ghada Kchour; Thierry Caus; Isabelle Six; Gabriel Choukroun; Saïd Kamel; Youssef Bennis
Journal:  Nephrol Dial Transplant       Date:  2019-07-01       Impact factor: 5.992

5.  Irisin improves endothelial function in type 2 diabetes through reducing oxidative/nitrative stresses.

Authors:  Di Zhu; Haichang Wang; Jinglong Zhang; Xiaotian Zhang; Chao Xin; Fuyang Zhang; Yan Lee; Ling Zhang; Kun Lian; Wenjun Yan; Xinliang Ma; Yi Liu; Ling Tao
Journal:  J Mol Cell Cardiol       Date:  2015-07-28       Impact factor: 5.000

6.  Intermedin1-53 attenuates vascular calcification in rats with chronic kidney disease by upregulation of α-Klotho.

Authors:  Jin Rui Chang; Jun Guo; Yue Wang; Yue Long Hou; Wei Wei Lu; Jin Sheng Zhang; Yan Rong Yu; Ming Jiang Xu; Xiu Ying Liu; Xiu Jie Wang; You Fei Guan; Yi Zhu; Jie Du; Chao Shu Tang; Yong Fen Qi
Journal:  Kidney Int       Date:  2016-01-28       Impact factor: 10.612

7.  Impact of Serum Bicarbonate Levels on Muscle Mass and Kidney Function in Pre-Dialysis Chronic Kidney Disease Patients.

Authors:  Piyawan Kittiskulnam; Somrath Srijaruneruang; Adhisabandh Chulakadabba; Nintita Sripaiboonkij Thokanit; Kearkiat Praditpornsilpa; Kriang Tungsanga; Somchai Eiam-Ong
Journal:  Am J Nephrol       Date:  2019-11-21       Impact factor: 3.754

8.  Endothelin-1 is a potent regulator in vivo in vascular calcification and in vitro in calcification of vascular smooth muscle cells.

Authors:  Sheng Ying Wu; Bao Hong Zhang; Chun Shui Pan; Hong Feng Jiang; Yong Zheng Pang; Chao Shu Tang; Yong Fen Qi
Journal:  Peptides       Date:  2003-08       Impact factor: 3.750

9.  A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis.

Authors:  Pontus Boström; Jun Wu; Mark P Jedrychowski; Anisha Korde; Li Ye; James C Lo; Kyle A Rasbach; Elisabeth Almer Boström; Jang Hyun Choi; Jonathan Z Long; Shingo Kajimura; Maria Cristina Zingaretti; Birgitte F Vind; Hua Tu; Saverio Cinti; Kurt Højlund; Steven P Gygi; Bruce M Spiegelman
Journal:  Nature       Date:  2012-01-11       Impact factor: 49.962

10.  Irisin promotes osteoblast proliferation and differentiation via activating the MAP kinase signaling pathways.

Authors:  Xiaoyong Qiao; Xiao Yong Qiao; Ying Nie; Yaxian Ma; Ya Xian Ma; Yan Chen; Ran Cheng; Weiyao Yin; Wei Yao Yinrg; Ying Hu; Wenming Xu; Wen Ming Xu; Liangzhi Xu; Liang Zhi Xu
Journal:  Sci Rep       Date:  2016-01-07       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.